/People

Olaf Christensen

CMO at Orum Therapeutics Venture Capital

Cambridge, Massachusetts, United States

Find your path to Olaf

Sign up to see every warm intro you have to Olaf

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Olaf. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Olaf Christensen is Chief Medical Officer at Orum Therapeutics, with 14 years of pharmaceutical industry experience in the clinical development of oncology compounds and more than five years of clinical oncology experience treating patients with solid tumors, leukemia, and lymphomas. He has served as program leader for gastric cancer, prostate cancer, pediatric development, and the ipilimumab Phase II-III program, and as global early clinical development project leader overseeing study teams across North America, Europe, and Asia. His work spans First in Patient, Proof of Concept, and Phase I studies, IND and IMPD preparation, translational medicine, and interactions with health authorities in the US and Europe.

Frequently asked questions

Who is Olaf Christensen?
Olaf Christensen is Chief Medical Officer at Orum Therapeutics, with 14 years of pharmaceutical industry experience in the clinical development of oncology compounds and more than five years of clinical oncology experience treating patients with solid tumors, leukemia, and lymphomas. He has served as program leader for gastric cancer, prostate cancer, pediatric development, and the ipilimumab Phase II-III program, and as global early clinical development project leader overseeing study teams across North America, Europe, and Asia. His work spans First in Patient, Proof of Concept, and Phase I studies, IND and IMPD preparation, translational medicine, and interactions with health authorities in the US and Europe.

About this profile. Compiled from public sources — the organisations' own websites and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights